Lanxess rebuilds on its recovery

Article Abstract:

Lanx ess is a speciality chemicals company that was spun-out of Bayer in 2004. Restructuring, cost-saving and portfolio changes have led to the raising of its EBITDA margin from 6.6% to 9.7% and the company has reduced its net debt-EBITDA ratio from 4.5 to less than 1. The other activities of the company which led to its recovery are discussed.

Germany, LANXESS Europe GmbH und Company KG

---

Akzo's transformational deals are still on course

Article Abstract:

Akzo Nobel is on its way to be a purely coatings and chemicals firm by the end of 2007, with 78.8% of its shareholders approving the acquisition of ICl. The selling of Organon BioSciences for 11 billion euros to Schering-Plough will also be completed by the year's end. The company's finances, facility closures and job cuts are also discussed.

Acquisitions & mergers, Organizational history, Netherlands, Mergers, acquisitions and divestments, Company acquisition/merger, Company restructuring/company reorganization, Reorganization and restructuring, Akzo Nobel N.V., Company organization

---

Similar abstracts:

• Abstracts: Lanxess makes its first acquisition as textile disposals are completed. Akzo Nobel sales completed
• Abstracts: In silico prediction of drug solubility: 1: Free energy of hydration. part 2 PECT model analysis and predictions of experimental collisional energy transfer probabilities P(E',E) and moments {delta E} for azulene and biphenylene
• Abstracts: Gas-phase conformations of proteolytically derived protein fragments: influence of solvent on peptide conformation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.